These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 22588186)

  • 21. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    Demeure F; Hanin FX; Bol A; Vincent MF; Pouleur AC; Gerber B; Pasquet A; Jamar F; Vanoverschelde JL; Vancraeynest D
    J Nucl Med; 2014 Oct; 55(10):1629-35. PubMed ID: 25082852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
    Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
    Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in Ireland.
    McCabe JJ; Giannotti N; McNulty J; Collins S; Coveney S; Murphy S; Barry M; Harbison J; Cronin S; Williams D; Horgan G; Dolan E; Cassidy T; McDonnell C; Kavanagh E; Foley S; O'Connell M; Marnane M; Kelly P
    BMJ Open; 2020 Jul; 10(7):e038607. PubMed ID: 32690537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
    Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT.
    Lensen KDF; van Sijl AM; Voskuyl AE; van der Laken CJ; Heymans MW; Comans EFI; Nurmohamed MT; Smulders YM; Boellaard R
    PLoS One; 2017; 12(8):e0181847. PubMed ID: 28800625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
    Hjelmgren O; Johansson L; Prahl U; Schmidt C; Fredén-Lindqvist J; Bergström GML
    Eur J Radiol; 2014 Jul; 83(7):1184-1189. PubMed ID: 24767629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
    Mani V; Woodward M; Samber D; Bucerius J; Tawakol A; Kallend D; Rudd JH; Abt M; Fayad ZA
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):571-82. PubMed ID: 24458953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
    Li M; Li L; Wu W; Jiang Y; Zhang P
    Int Angiol; 2019 Dec; 38(6):443-450. PubMed ID: 31782278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent Carotid Inflammation in Acute Coronary Syndrome as Assessed by (18)F-FDG PET/CT: A Possible Mechanistic Link for Ischemic Stroke.
    Kim S; Lee S; Kim JB; Na JO; Choi CU; Lim HE; Rha SW; Park CG; Oh DJ; Yoo H; Kim JW
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2547-54. PubMed ID: 26306455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.
    Myers KS; Rudd JH; Hailman EP; Bolognese JA; Burke J; Pinto CA; Klimas M; Hargreaves R; Dansky HM; Fayad ZA
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):38-45. PubMed ID: 22239891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events.
    Cocker MS; Spence JD; Hammond R; deKemp RA; Lum C; Wells G; Bernick J; Hill A; Nagpal S; Stotts G; Alturkustani M; Adeeko A; Yerofeyeva Y; Rayner K; Peterson J; Khan AR; Naidas AC; Garrard L; Yaffe MJ; Leung E; Prato FS; Tardif JC; Beanlands RSB;
    Int J Cardiol; 2018 Nov; 271():378-386. PubMed ID: 30007487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.